Moreover, ATR–CHK1 blockade induces the accumulation of cytosolic double-stranded DNA and micronuclei, which in turn activate the cGAS/STING pathway, leading to type I interferon responses and a pro-inflammatory tumor microenvironment. Here, STING1 is linked to neoplasm.